CN1636070A - 编码一种g蛋白偶联受体的核酸及其用途 - Google Patents

编码一种g蛋白偶联受体的核酸及其用途 Download PDF

Info

Publication number
CN1636070A
CN1636070A CNA028265556A CN02826555A CN1636070A CN 1636070 A CN1636070 A CN 1636070A CN A028265556 A CNA028265556 A CN A028265556A CN 02826555 A CN02826555 A CN 02826555A CN 1636070 A CN1636070 A CN 1636070A
Authority
CN
China
Prior art keywords
gave18
protein
nucleic acid
expression
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028265556A
Other languages
English (en)
Chinese (zh)
Inventor
H·埃辛德雷罗
蔡济东
S·J·布什
J·加森胡贝尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0206891.4A external-priority patent/GB0206891D0/en
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of CN1636070A publication Critical patent/CN1636070A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA028265556A 2001-11-13 2002-11-08 编码一种g蛋白偶联受体的核酸及其用途 Pending CN1636070A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35415001P 2001-11-13 2001-11-13
US60/354,150 2001-11-13
GBGB0206891.4A GB0206891D0 (en) 2001-11-13 2002-03-22 A nucleic acid encoding a g-protein-coupled receptor and uses thereof
GB0206891.4 2002-03-22

Publications (1)

Publication Number Publication Date
CN1636070A true CN1636070A (zh) 2005-07-06

Family

ID=26247015

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028265556A Pending CN1636070A (zh) 2001-11-13 2002-11-08 编码一种g蛋白偶联受体的核酸及其用途

Country Status (11)

Country Link
EP (1) EP1573028A2 (no)
JP (1) JP2005515760A (no)
KR (1) KR20050044461A (no)
CN (1) CN1636070A (no)
BR (1) BR0214118A (no)
CA (1) CA2466521A1 (no)
IL (1) IL161952A0 (no)
MX (1) MXPA04004434A (no)
NO (1) NO20042386L (no)
RU (1) RU2004117891A (no)
WO (1) WO2003042399A2 (no)

Also Published As

Publication number Publication date
IL161952A0 (en) 2005-11-20
WO2003042399A8 (en) 2005-11-17
NO20042386L (no) 2004-06-08
MXPA04004434A (es) 2004-11-29
KR20050044461A (ko) 2005-05-12
EP1573028A2 (en) 2005-09-14
WO2003042399A9 (en) 2004-04-29
RU2004117891A (ru) 2005-03-27
JP2005515760A (ja) 2005-06-02
WO2003042399A2 (en) 2003-05-22
BR0214118A (pt) 2005-02-09
CA2466521A1 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
US20030166200A1 (en) 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses thereof
CN1665840A (zh) 含有免疫球蛋白结构域的细胞表面识别分子
CN1620467A (zh) 分泌性蛋白质
US6972187B2 (en) OAT5 molecules and uses therefor
CN1620466A (zh) 胱氨酸结折迭蛋白质
CN1372594A (zh) Ox2受体的同系物
CN1615439A (zh) 编码g蛋白偶联受体的基因及其使用方法
CN1642971A (zh) 编码g－蛋白质－偶联之受体的核酸及其用途
CN1813187A (zh) 编码g－蛋白质－偶联之受体的核酸及其用途
CN1898263A (zh) 编码新的前列腺素受体蛋白的核酸及其使用方法
CN1636070A (zh) 编码一种g蛋白偶联受体的核酸及其用途
CN1346368A (zh) 钾通道互作剂及其用途
JP2002516079A (ja) 新規分泌型および膜会合型タンパク質ならびにそのための用途
US20020151046A1 (en) 52871, a novel human G protein coupled receptor and uses thereof
CN1596269A (zh) 一种新型g蛋白偶联受体:gave10
CN1714151A (zh) 新的谷氨酸受体调节蛋白和核酸分子及其用途
HK1071381A (en) A novel g protein-coupled receptor, gave 10
JP2002525117A (ja) Ｓｌｇｐタンパク質及び核酸分子並びにそれらの使用
US20030138418A1 (en) Nucleic acid encoding a G-protein-coupled receptor, and uses thereof
JP2005514934A (ja) Ｇタンパク質共役受容体をコードする核酸、およびその使用
KR20040088072A (ko) Ｇ-단백질 결합된 수용체를 암호화하는 핵산 및 이의 용도
US20020177148A1 (en) FBH58295FL, a novel human amino acid transporter and uses thereof
AU2671399A (en) Neokine protein and nucleic acid molecules and uses therefor
JP2005500036A (ja) 新規のｇタンパク質共役受容体、ｇａｖｅ３
HK1046914A1 (zh) 鉀通道互作劑及其用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication